FABP4 and acute kidney injury: FABP4 has reported to be potential for pre‐clinical application as a biomarker of drug‐induced kidney injury, and cisplatin had no effect on the urinary and serum levels of FABP4.22 However, the function and mechanism of kidney‐expressed FABP4 in cisplatin‐induced AKI remained unknown.